PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic kidney diseases |
| Phenotype | C0023895|liver disease |
| Sentences | 7 |
| PubMedID- 20236458 | Autosomal-dominant polycystic kidney disease is associated with polycystic liver disease in up to 75-90% of cases [11]. |
| PubMedID- 20185596 | Background and objectives: no medical treatment is available for polycystic liver disease, a frequent manifestation of autosomal-dominant polycystic kidney disease (adpkd). |
| PubMedID- 23914068 | It is a fibrocystic liver disease associated withautosomal recessive polycystic kidney disease. |
| PubMedID- 23499726 | Background & aims: polycystic liver disease (pld) is associated with autosomal dominant polycystic kidney disease (adpkd) or autosomal dominant polycystic liver disease (pcld). |
| PubMedID- 24987537 | Combined liver and kidney transplant in a patient with budd-chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up. |
| PubMedID- 24325362 | Autosomal-dominant polycystic kidney disease is frequently complicated by polycystic liver disease. |
| PubMedID- 22773240 | Background: we showed in a randomized double-blinded placebo-controlled clinical trial that octreotide long-acting repeatable depot.(r) (octlar((r))) for 12 months reduces kidney and liver growth in autosomal dominant polycystic kidney patients with severe polycystic liver disease (pld) and liver growth in patients with severe isolated pld. |
Page: 1